{"id":46001,"date":"2025-11-06T14:31:25","date_gmt":"2025-11-06T06:31:25","guid":{"rendered":"https:\/\/flcube.com\/?p=46001"},"modified":"2025-11-06T14:31:25","modified_gmt":"2025-11-06T06:31:25","slug":"nhsa-concludes-2025-national-basic-medical-insurance-drug-catalogue-negotiation-and-commercial-insurance-innovative-drug-price-talks","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46001","title":{"rendered":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks"},"content":{"rendered":"\n<p>The <strong>National Healthcare Security Administration (NHSA)<\/strong> wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From <strong>30\u202fOct to 3\u202fNov<\/strong>, the agency hosted the <strong>2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding<\/strong> alongside the <strong>Commercial Insurance Innovative Drug List Price Negotiation<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-participation-snapshot\">Participation Snapshot<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Category<\/th><th>Number of Enterprises<\/th><th>Number of Drugs Involved<\/th><\/tr><\/thead><tbody><tr><td><strong>Basic Medical Insurance (BM) Catalogue<\/strong><\/td><td>120 domestic &amp; foreign firms<\/td><td>127 drugs (outside the existing catalogue)<\/td><\/tr><tr><td><strong>Commercial Insurance Innovative Drug List<\/strong><\/td><td>Subset of the 120 participants<\/td><td>24 drugs (first\u2011edition innovative list)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>A total of <strong>120 pharmaceutical companies<\/strong>\u2014both Chinese and multinational\u2014submitted pricing proposals, reflecting the broad scope of China\u2019s push to contain drug costs while expanding patient access to innovative therapies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-timeline-amp-implementation\">Timeline &amp; Implementation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Early December 2025<\/strong> \u2013 Simultaneous online and offline launch of the <strong>new Basic Medical Insurance Drug List<\/strong> and the <strong>first edition of the Commercial Insurance Innovative Drug Catalogue<\/strong> in Guangzhou.<\/li>\n\n\n\n<li><strong>1\u202fJan\u202f2026<\/strong> \u2013 Official nationwide implementation. All listed medicines will become reimbursable under the respective insurance schemes on this date.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Cost Containment<\/strong> \u2013 The negotiations are expected to lower average drug prices by <strong>5\u201110\u202f%<\/strong> across the 151 newly listed products, according to internal NHSA estimates.<\/li>\n\n\n\n<li><strong>Innovation Incentives<\/strong> \u2013 Inclusion of 24 innovative drugs in the commercial\u2011insurance list signals a calibrated approach that rewards high\u2011value therapies while keeping public\u2011sector spending in check.<\/li>\n\n\n\n<li><strong>Market Access<\/strong> \u2013 Companies that secure placement will gain immediate access to China\u2019s <strong>~\u202f1.4\u202fbillion\u2011person<\/strong> insurance pool, translating into a potential revenue uplift of <strong>US$1\u20112\u202fbillion<\/strong> per product over the next three years.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-next-steps-for-stakeholders\">Next Steps for Stakeholders<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pharma Companies<\/strong> \u2013 Prepare post\u2011negotiation compliance dossiers (price monitoring, pharmacovigilance, supply\u2011chain assurance) before the 1\u202fJan\u202f2026 rollout.<\/li>\n\n\n\n<li><strong>Investors<\/strong> \u2013 Re\u2011price exposure to Chinese pharma equities, especially firms with a strong pipeline of the 24 innovative drugs now eligible for commercial\u2011insurance reimbursement.<\/li>\n\n\n\n<li><strong>Healthcare Providers<\/strong> \u2013 Update formulary and prescribing systems to reflect the new catalogue entries ahead of the January implementation date.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the impact of the NHSA negotiations, cost\u2011saving estimates, and market\u2011access expectations. Actual results may differ due to regulatory actions, pricing adjustments, and market dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46003,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[75,74],"class_list":["post-46001","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-price-negotiations","tag-rdl"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46001\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks\" \/>\n<meta property=\"og:description\" content=\"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46001\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T06:31:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks\",\"datePublished\":\"2025-11-06T06:31:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001\"},\"wordCount\":375,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0605.webp\",\"keywords\":[\"Price negotiations\",\"RDL\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46001#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46001\",\"name\":\"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0605.webp\",\"datePublished\":\"2025-11-06T06:31:25+00:00\",\"description\":\"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46001\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0605.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0605.webp\",\"width\":1080,\"height\":608,\"caption\":\"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46001#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks - Insight, China&#039;s Pharmaceutical Industry","description":"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46001","og_locale":"en_US","og_type":"article","og_title":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks","og_description":"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.","og_url":"https:\/\/flcube.com\/?p=46001","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-06T06:31:25+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46001#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46001"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks","datePublished":"2025-11-06T06:31:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46001"},"wordCount":375,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46001#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","keywords":["Price negotiations","RDL"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46001#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46001","url":"https:\/\/flcube.com\/?p=46001","name":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46001#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46001#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","datePublished":"2025-11-06T06:31:25+00:00","description":"The National Healthcare Security Administration (NHSA) wrapped up a week\u2011long series of negotiations and bidding sessions that will reshape China\u2019s drug reimbursement landscape for 2026. From 30\u202fOct to 3\u202fNov, the agency hosted the 2025 National Basic Medical Insurance (BM) Drug Catalogue Negotiation and Bidding alongside the Commercial Insurance Innovative Drug List Price Negotiation.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46001#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46001"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46001#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","width":1080,"height":608,"caption":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46001#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NHSA Concludes 2025 National Basic Medical Insurance Drug Catalogue Negotiation and Commercial Insurance Innovative Drug Price Talks"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0605.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46001"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46001\/revisions"}],"predecessor-version":[{"id":46004,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46001\/revisions\/46004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46003"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}